Annual Report

The report describes Gubra's record 2025, with consolidated revenue of DKK 2,637 million driven by the AbbVie out-licensing deal. It reports a validated target to reduce absolute Scope 1 and 2 emissions by 50% by 2030 and details major renewable-energy investments. The ESG section also presents Scope 3 emissions of 6,863.7 tCO2e and a broad sustainability disclosure covering materiality, laboratories, nature, and workforce matters.